ALZN Stock Discussion
Alzamend Neuro, Inc. Description
Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company's lead product candidate is AL001 for the treatment of Alzheimer's and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient's immunological system to Alzheimer's. The company was incorporated in 2016 and is headquartered in Tampa, Florida.
Industry: Biotechnology
Keywords: Life Sciences Biology Medication Neuroscience Alzheimer's Disease Neurodegenerative Diseases Dementia Psychiatric Diagnosis Amyloidosis Neurodegeneration Preclinical Stage Biopharmaceutical Psychiatric Disorders Treatment Of Neurodegenerative Diseases Treatment Of Alzheimer's
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Popular Now
Featured Articles